Denosumab Decreases Cortical Porosity in Postmenopausal Women with Low Bone Mineral Density

被引：0

作者：

Libanati, C. ^{[1
]}

Boyd, S. K. ^{[2
]}

Nishiyama, K. K. ^{[2
]}

Zebaze, R. M.

Hanley, D. A. ^{[2
]}

Zanchetta, J. R. ^{[3
]}

Thomas, Thierry ^{[4
,5
]}

Boutroy, S. ^{[6
,7
]}

Bogado, C. E. ^{[3
]}

Austin, M. ^{[1
]}

Seeman, E. ^{[8
]}

机构：

[1] Amgen Inc, Thousand Oaks, CA 91320 USA

[2] Univ Calgary, Calgary, AB, Canada

[3] Inst Invest Metabol, Buenos Aires, DF, Argentina

[4] Univ Hosp, St Etienne, France

[5] INSERM, U1059, St Etienne, France

[6] Univ Lyon, Lyon, France

[7] INSERM, U831, F-69008 Lyon, France

[8] Univ Melbourne, Austin & Repatriat Med Ctr, Melbourne, Vic, Australia

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1631

引用

页码：S637 / S638

页数：2

共 50 条

[11] Early Effects of Denosumab in Postmenopausal Women with Low Bone Mineral Density Previously Treated with Alendronate
Brown, J. P.
Kendler, D. L.
Benhamou, C. L.
Lillestol, M.
Roux, C.
Siddhanti, S.
Man, H. S.
Martin, J. San
Bone, H. G.
ARTHRITIS AND RHEUMATISM, 2008, 58 (12): : 3973 - 3974
[12] Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density
Genant, H. K.
Engelke, K.
Hanley, D. A.
Brown, J. P.
Omizo, M.
Bone, H. G.
Kivitz, A. J.
Fuerst, T.
Wang, H.
Austin, M.
Libanati, C.
BONE, 2010, 47 (01) : 131 - 139
[13] Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
Bone, Henry G.
Bolognese, Michael A.
Yuen, Chui Kin
Kendler, David L.
Miller, Paul D.
Yang, Yu-Ching
Grazette, Luanda
San Martin, Javier
Gallagher, J. Christopher
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (04): : 972 - 980
[14] EFFECTS OF DENOSUMAB ON BONE MINERAL DENSITY IN POSTMENOPAUSAL WOMEN TRANSITIONING FROM RALOXIFENE
Yeh, K. T.
Wu, W. -T.
Thu, C. -H.
Wang, J. -H.
OSTEOPOROSIS INTERNATIONAL, 2014, 25 : 573 - 573
[15] Romosozumab in Postmenopausal Women with Low Bone Mineral Density
McClung, Michael R.
Grauer, Andreas
Boonen, Steven
Bolognese, Michael A.
Brown, Jacques P.
Diez-Perez, Adolfo
Langdahl, Bente L.
Reginster, Jean-Yves
Zanchetta, Jose R.
Wasserman, Scott M.
Katz, Leonid
Maddox, Judy
Yang, Yu-Ching
Libanati, Cesar
Bone, Henry G.
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (05): : 412 - 420
[16] Romosozumab in postmenopausal women with low bone mineral density
Tornero Marin, C.
REVISTA CLINICA ESPANOLA, 2014, 214 (06): : 345 - 345
[17] Romosozumab in postmenopausal women with low bone mineral density
Schurman, Leon
ACTUALIZACIONES EN OSTEOLOGIA, 2014, 10 (02) : 206 - 208
[18] Effect of Denosumab on Bone Mineral Density and Markers of Bone Turnover among Postmenopausal Women with Osteoporosis
Sanchez, A.
Brun, L. R.
Salerni, H.
Costanzo, P. R.
Gonzalez, D.
Bagur, A.
Oliveri, B.
Zanchetta, M. B.
Farias, V.
Maffei, L.
Premrou, V.
Mansur, J. L.
Larroude, M. S.
Sarli, M. A.
Rey, P.
Ulla, M. R.
Pavlove, M. M.
Karlsbrum, S.
Brance, M. L.
JOURNAL OF OSTEOPOROSIS, 2016, 2016
[19] Hip Cortical Porosity Predicts Fragility Fractures in Postmenopausal Women with Normal Hip Bone Mineral Density and Osteopenia
Ahmed, Luai A.
Shigdel, Rajesh
Joakimsen, Ragnar
Eldevik, Petter
Eriksen, Erik Fink
Zebaze, Roger
Bjornerem, Ashild
JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
[20] Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis
von Keyserlingk, Camilla
Hopkins, Robert
Anastasilakis, Athanasios
Toulis, Konstantinos
Goeree, Ron
Tarride, Jean-Eric
Xie, Feng
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (02) : 178 - 186

← 1 2 3 4 5 →